Altrius Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$2.12M |
| 2 |
B&G Foods
BGS
|
+$1.42M |
| 3 |
VF Corp
VFC
|
+$907K |
| 4 |
Philip Morris
PM
|
+$728K |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$624K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$794K |
| 2 |
Eastman Chemical
EMN
|
+$718K |
| 3 |
Cardinal Health
CAH
|
+$201K |
| 4 |
Cigna
CI
|
+$191K |
| 5 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$164K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.45% |
| 2 | Financials | 15.78% |
| 3 | Consumer Staples | 11.15% |
| 4 | Industrials | 10.74% |
| 5 | Consumer Discretionary | 9.94% |
Similar funds
Altrius Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Altrius Capital Management held 94 positions worth $319M, up 22% from $262M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Altrius Capital Management deployed $11.1M of net new capital in Q4 2022, opening 7 new positions and adding to 50 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 7,137 shares worth $2.2M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was 3M, an estimated $794K trimmed.
- Altrius Capital Management's largest Q4 2022 buy was Berkshire Hathaway Class B: 7,137 shares worth $2.2M.
- Altrius Capital Management added most to B&G Foods in Q4 2022, an estimated $1.42M increase.
- Altrius Capital Management's biggest Q4 2022 reduction was 3M, cutting an estimated $794K.
- Altrius Capital Management's ten largest holdings make up 21% of its $319M portfolio in Q4 2022.
- Altrius Capital Management opened 7 new positions and closed 0 in Q4 2022.
- Altrius Capital Management's portfolio value rose 22% quarter-over-quarter to $319M.
Based on Altrius Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.